Prognostic biomarkers in osteoarthritis

Current Opinion in Rheumatology

Volumn 25, Issue 1, 2013, Pages 136-144

  Attur, Mukundan ^a   Krasnokutsky Samuels, Svetlana ^a   Samuels, Jonathan ^a   Abramson, Steven B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; inflammation; osteoarthritis; progression

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INTERLEUKIN 6; TRANSCRIPTOME;

BONE DEFECT; CARTILAGE DEGENERATION; DISEASE COURSE; HIGH RISK PATIENT; HUMAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; NONHUMAN; OBESITY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; SYNOVIAL FLUID;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; INFLAMMATION MEDIATORS; OSTEOARTHRITIS; PROGNOSIS;

EID: 84871225156     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32835a9381     Document Type: Review

References (59)

1. Kraus VB, Burnett B, Coindreau J, et al. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoar-thritis Cartilage 2011; 19:515-542.
2. Bauer DC, Hunter DJ, Abramson SB, et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage 2006; 14:723-727.
3. Abramson SB, Berenbaum F, Hochberg MC, Moskowitz RW. Introduction to OARSI FDA initiative OAC special edition: clinical development programs for drugs, devices, and biological products intendedforthetreatmentofosteoar-thritis (OA). Osteoarthritis Cartilage 2011; 19:475-477.
4. Rousseau JC, Garnero P. Biological markers in osteoarthritis. Bone 2012;51:265-277.
5. Henrotin Y, Martel-Pelletier J, Msika P, et al. Usefulness of specific OA biomarkers, Coll2-1 and Coll2-1NO2, in the anterior cruciate ligament OA canine model. Osteoarthritis Cartilage 2012; 20:787-790.
6. Mobasheri A. Osteoarthritis year 2012 in review: biomarkers. Osteoarthritis Cartilage 2012; 20:1451-1464.
7. Patra D, Sandell LJ. Recent advances in biomarkers in osteoarthritis. Curr Opin Rheumatol 2011; 23:465-470.
8. Garnero P. Use of biochemical markers to study and follow patients with osteoarthritis. Curr Rheumatol Rep 2006; 8:37-44.
9. Hoch JM, Mattacola CG, Medina Mc Keon JM, et al. Serum cartilage oligo-meric matrix protein (s COMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage 2011; 19:1396-1404.
10. Vilim V, Olejarova M, Machacek S, et al. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 2002; 10:707-713.
11. Sharif M, Kirwan JR, Elson CJ, et al. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum 2004; 50:2479-2488.
12. Golightly YM, Marshall SW, Kraus VB, et al. Biomarkers of incident radio-graphic knee osteoarthritis: do they vary by chronic knee symptoms? Arthritis Rheum 2011; 63:2276-2283.
13. Hunter DJ, Li J, La Valley M, et al. Cartilage markers and theirassociation with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study. Arthritis Res Ther 2007; 9:R108.
14. Eckstein F, Le Graverand MP, Charles HC, et al. Clinical, radiographic, molecular and MRI-based predictors of cartilage loss in knee osteoarthritis. Ann Rheum Dis 2011; 70:1223-1230.
15. Pelletier JP, Raynauld JP, Caron J, et al. Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoar-thritis drugs assessed by quantitative MRI in patients with knee osteoarthritis. Ann Rheum Dis 2010; 69:2095-2101.
16. Kumm J, Tamm A, Lintrop M, Tamm A. The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-yearfollow-up study in middle-aged subjects. Rheumatol Int 2012. [Epub ahead of print]
17. Erhart-Hledik JC, Favre J, Asay JL, et al. A relationship between mechanically-induced changes in serum cartilage oligomeric matrix protein (COMP) and changes in cartilage thickness after 5 years. Osteoarthritis Cartilage 2012; 20:1309-1315.
18. Lai Y, Yu XP, Zhang Y, et al. Enhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISA. Osteoarthritis Cartilage 2012; 20:854-862.
19. Garnero P, Ayral X, Rousseau JC, et al. Uncoupling of type II collagen synthesis and degradation predicts progression ofjoint damage in patients with knee osteoarthritis. Arthritis Rheum 2002; 46:2613-2624.
20. Reijman M, Hazes JM, Bierma-Zeinstra SM, et al. A new marker for osteoar-thritis: cross-sectional and longitudinal approach. Arthritis Rheum 2004; 50:2471-2478.
21. Garnero P, Mazieres B, Gueguen A, et al. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J Rheumatol 2005; 32:697-703.
22. Mazieres B, Garnero P, Gueguen A, et al. Molecular markers of cartilage breakdown and synovitis at baselineas predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis 2006; 65:354-359.
23. Garnero P, Peterfy C, Zaim S, Schoenharting M. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degrada-tion in knee osteoarthritis: a three-month longitudinal study. Arthritis Rheum 2005; 52:2822-2829.
24. Bingham CO III, Buckland-Wright JC, Garnero P, et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational kneeosteoarthritisstructural arthritisstudy. Arthritis Rheum 2006; 54:3494-3507.
25. Conrozier T, Balblanc JC, Richette P, et al. Earlyeffect of hyaluronicacid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: an open-label observational prospective study. J Orthop Res 2012; 30:679-685.
26. Van Spil WE, Jansen NW, Bijlsma JW, et al. Clusters within awidespectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis. Osteoarthritis Cartilage 2012; 20:745-754.
27. Fernandez-Puente P, Mateos J, Fernandez-Costa C, et al. Identification of a panel of novel serum osteoarthritis biomarkers. J Proteome Res 2011; 10:5095-5101.
28. Fukuda I, Ishihara T, Ohmachi S, et al. Potential plasma biomarkers for progression of knee osteoarthritis using glycoproteomic analysis coupled with a 2D-LC-MALDI system. Proteome Sci 2012; 10:36.
29. Henrotin Y, Gharbi M, Mazzucchelli G, et al. Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis. Arthritis Rheum 2012; 64:2260-2267.
30. Wang Y, Li D, Xu N, et al. Follistatin-like protein 1: a serum biochemical marker reflecting the severity ofjoint damage in patients with osteoarthritis. Arthritis Res Ther 2011; 13:R193.
31. Cohen SB, Proudman S, Kivitz AJ, et al. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther 2011; 13:R125.
32. Stannus OP, Jones G, Blizzard L, et al. Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study. Ann Rheum Dis 2012. [Epub ahead of print]
33. Richette P, Poitou C, Garnero P, et al. Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Ann Rheum Dis 2011; 70:139-144.
34. Denoble AE, Huffman KM, Stabler TV, et al. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci USA 2011; 108:2088-2093.
35. Fraenkel L, Roubenoff R, La Valley M, et al. The association of peripheral monocyte derived interleukin 1beta (IL-1beta), IL-1 receptorantagonist, and tumor necrosis factor-alpha with osteoarthritis in the elderly. J Rheumatol 1998; 25:1820-1826.
36. Attur M, Statnikov A, Aliferis CF, et al. Inflammatory genomic and plasma biomarkers predict progression of symptomatic knee osteoarthritis (SKOA) [abstract]. Osteoarthritis Cartilage 2012; 20:S34-S35.
37. Attur M, Belitskaya-Levy I, Oh C, et al. Increased interleukin-1beta gene expression in peripheral blood leukocytes is associated with increased pain and predicts riskfor progression ofsymptomatic knee osteoarthritis. Arthritis Rheum 2011; 63:1908-1917.
38. Sohn DH, Sokolove J, Sharpe O, et al. Plasma proteins present in osteoar-thritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res Ther 2012; 14:R7.
39. Stannus O, Jones G, Cicuttini F, et al. Circulating levelsof IL-6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage 2010; 18:1441-1447.
40. Vlad SC, Neogi T, Aliabadi P, et al. No association between markers of inflammation and osteoarthritis of the hands and knees. J Rheumatol 2011; 38:1665-1670.
41. Liu JX, Samuels J, Abramson SB, et al. The effect of laparoscopic adjustable gastric banding on osteoarthritis and other obesity-related comorbidities. J Obes Wt Loss Ther 2012; 2:138.
42. Rübenhagen R, Schuttrumpf JP, Sturmer KM, Frosch KH. Interleukin-7 levels in synovial fluid increase with age and MMP-1 levels decrease with progres-sion of osteoarthritis. Acta Orthop 2012; 83:59-64.
43. Kyostio-Moore S, Nambiar B, Hutto E, et al. STR/ort mice, a model for spontaneous osteoarthritis, exhibit elevated levels of both local and systemic inflammatory markers. Comp Med 2011; 61:346-355.
44. Nemirovskiy O, Buck R, Sunyer T, et al. Predicting radiographic joint space narrowing (JSN) using biomarkers for osteoarthritis (OA) clinical trials [abstract]. Osteoarthritis Cartilage 2008; 16:S56-S57.
45. Wang Q, Rozelle AL, Lepus CM, et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011; 17:1674-1679.
46. Koskinen A, Juslin S, Nieminen R, et al. Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proin-flammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res Ther 2011; 13:R184.
47. Krasnokutsky S, Belitskaya-Levy I, Bencardino J, et al. Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radio-graphic severityofknee osteoarthritis. Arthritis Rheum 2011; 63:2983-2991.
48. Guermazi A, Roemer FW, Hayashi D, et al. Assessment of synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in people with, or at high risk of, knee osteoarthritis: the MOST study. Ann Rheum Dis 2011; 70:805-811.
49. Ayral X, Pickering EH, Woodworth TG, et al. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis: results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoar-thritis Cartilage 2005; 13:361-367.
50. Abramson SB, Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther 2009; 11:227.
51. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001; 44:1237-1247.
52. Attur MG, Patel IR, Patel RN, et al. Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8. Proc Assoc Am Physicians 1998; 110:65-72.
53. Ling SM, Patel DD, Garnero P, et al. Serum protein signatures detect early radiographic osteoarthritis. Osteoarthritis Cartilage 2009; 17:43-48.
54. Baker KR, Matthan NR, Lichtenstein AH, et al. Association of plasma n-6 and n-3 polyunsaturated fatty acids with synovitis in the knee: the MOST study. Osteoarthritis Cartilage 2012; 20:382-387.
55. Long D, Blake S, Song XY, et al. Human articular chondrocytes produce IL-7 and respond to IL-7 with increased production of matrix metalloproteinase-13. Arthritis Res Ther 2008; 10:R23.
56. Yusuf E, Nelissen RG, Ioan-Facsinay A, et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis 2010; 69:761-765.
57. Issa RI, Griffin TM. Pathobiology of obesity and osteoarthritis: integrating biomechanics and inflammation. Pathobiol Aging Age Relat Dis 2012; 2:17470.
58. Colitti M, Gaspardo B, Della PA, et al. Transcriptome modification of white blood cells after dietary administration of curcumin and nonsteroidal anti-inflammatory drug in osteoarthritic affected dogs. Vet Immunol Immunopathol 2012; 147:136-146.
59. Hirohata S, Yanagida T, Tomita T, Yoshikawa H. Enhanced expression of m RNAfor interleukin 6 and tumor necrosisfactor-alpha in CD34+ cellsof the bone marrow in osteoarthritis [abstract #1771]. Arthritis Rheum 2011; 63:S694.